Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/4509
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarvey, Ken-
dc.date.accessioned2023-04-10T04:03:49Z-
dc.date.available2023-04-10T04:03:49Z-
dc.date.issued2021-12-
dc.identifier.issn1753-6405.13161-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/4509-
dc.description.abstractObjective: Investigate the response of the Therapeutic Goods Administration’s (TGA) new advertising complaint system to resubmitted complaints about complementary medicine weight loss products previously upheld by the Complaint Resolution Panel. Methods: Between July 2018 and July 2019, complaints about a convenience sample of 22 complementary medicines by eight sponsors, advertised on 140 different internet sites (cases), were resubmitted to the TGA. FatBlaster products featured. Follow-up occurred in February 2021. Results: A search of the TGA advertising complaints database found ‘no result’ for 84% of the 140 cases submitted. Despite the TGA delisting three products and sponsors delisting ten others, all products complained about were still being advertised. Some products had minor changes in imagery but not claims. The sponsor (Cat Media, Naturopathica) had listed three new FatBlaster weight loss products. Conclusions: The TGA failed to protect consumers from ineffective weight loss medicines. Implications for public health: Weight loss medicines with misleading and deceptive claims are likely to divert users from evidence-based weight loss activities. The TGA should ask for the evidence supporting promotional claims for these products and, if this is lacking, delist the entire class of products. For recalcitrant sponsors who repeatedly make egregious claims, civil and criminal penalties should be applied.en_US
dc.language.isoen_USen_US
dc.publisherAustralian and New Zealand Journal of Public Healthen_US
dc.relation.ispartofseriesHealth Promotion;584-586-
dc.subjectcomplementary medicinesen_US
dc.subjectregulationen_US
dc.subjectpromotionen_US
dc.subjectobesity epidemicen_US
dc.titleThe Australian obesity epidemic and the regulation of complementary medicine weight loss productsen_US
dc.typeArticleen_US
Appears in Collections:VOL 45 NO 6

Files in This Item:
File Description SizeFormat 
584-586.pdf103.38 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.